Abstract
The role of melatonin in glucose homeostasis is an active area of investigation. There is a growing body of evidence suggesting a link between disturbances in melatonin production and impaired insulin, glucose, lipid metabolism, and antioxidant capacity. Furthermore, melatonin has been found to influence insulin secretion both in vivo and in vitro, and night-time melatonin levels are related to night-time insulin concentrations in patients with diabetes. In several recent studies, a single nucleotide polymorphism of the human melatonin receptor 1B has been described as being causally linked to an increased risk of developing type 2 diabetes. Taken together, these data suggest that endogenous as well as exogenous melatonin may play a role in diabetes and associated metabolic disturbances not only by regulating insulin secretion but also by providing protection against reactive oxygen species, considering pancreatic β-cells are particularly susceptible to oxidative stress because they possess only low-antioxidative capacity.
Keywords: Diabetes, glucagon, glucose, insulin, melatonin, melatonin receptors, metabolic syndrome, oxidative stress.
Current Pharmaceutical Design
Title:Melatonin and Glucose Metabolism: Clinical Relevance
Volume: 20 Issue: 30
Author(s): Lardone P.J., Alvarez-Sanchez Sanchez N., Guerrero J.M. and Carrillo-Vico A.
Affiliation:
Keywords: Diabetes, glucagon, glucose, insulin, melatonin, melatonin receptors, metabolic syndrome, oxidative stress.
Abstract: The role of melatonin in glucose homeostasis is an active area of investigation. There is a growing body of evidence suggesting a link between disturbances in melatonin production and impaired insulin, glucose, lipid metabolism, and antioxidant capacity. Furthermore, melatonin has been found to influence insulin secretion both in vivo and in vitro, and night-time melatonin levels are related to night-time insulin concentrations in patients with diabetes. In several recent studies, a single nucleotide polymorphism of the human melatonin receptor 1B has been described as being causally linked to an increased risk of developing type 2 diabetes. Taken together, these data suggest that endogenous as well as exogenous melatonin may play a role in diabetes and associated metabolic disturbances not only by regulating insulin secretion but also by providing protection against reactive oxygen species, considering pancreatic β-cells are particularly susceptible to oxidative stress because they possess only low-antioxidative capacity.
Export Options
About this article
Cite this article as:
P.J. Lardone, Sanchez N. Alvarez-Sanchez, J.M. Guerrero and A. Carrillo-Vico, Melatonin and Glucose Metabolism: Clinical Relevance, Current Pharmaceutical Design 2014; 20 (30) . https://dx.doi.org/10.2174/1381612819666131119101032
DOI https://dx.doi.org/10.2174/1381612819666131119101032 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Crosstalk between Gut Inflammation and Gastrointestinal Disorders During Acute Pancreatitis
Current Pharmaceutical Design Chemoprevention of Colorectal Carcinogenesis by Natural Anti-Inflammatory Agents
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry High-Throughput Structural Biology in Drug Discovery: Protein Kinases
Current Pharmaceutical Design Meet Our Editorial Board Member
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Wound Repair - Updates in Dressing Patents and Regeneration Biomarkers
Recent Patents on Biomarkers Overview on Anticancer Drug Design and Development
Current Medicinal Chemistry The Potential of p38 MAPK Inhibitors to Modulate Periodontal Infections
Current Drug Metabolism Indications for Surgery and Operative Techniques in Infective Endocarditis in the Present Day
Infectious Disorders - Drug Targets Gender Disparities on Access to Care and Coronary Disease Management
Current Pharmaceutical Design Beneficial Effects of the Mediterranean Diet on Metabolic Syndrome
Current Pharmaceutical Design Silymarin as a New Hepatoprotective Agent in Experimental Cholestasis: New Possibilities for an Ancient Medication
Current Medicinal Chemistry Editorial: The New Pharmacognosy
Combinatorial Chemistry & High Throughput Screening Macrophages: Promising Targets for the Treatment of Atherosclerosis
Current Vascular Pharmacology Clinical Implications of Recent Insights into the Structural Biology of Beta2 Adrenoceptors
Current Drug Targets Targeting Tyrosine Kinase Receptors in Hepatocellular Carcinoma
Current Cancer Drug Targets Threat Posed by Persistent Organochlorine Pesticides and their Mobility in the Environment
Current Organic Chemistry Meet the Editorial Board:
Current Drug Targets Time Trends and Gender Differences in Incidence and Prevalence of Type 1 Diabetes in Sweden
Current Diabetes Reviews Caveolin Involvement and Modulation in Breast Cancer
Mini-Reviews in Medicinal Chemistry Prevalence of Diabetes Ketoacidosis Rises and Still No Strict Treatment Adherence
Current Diabetes Reviews